Literature DB >> 28719298

Cognitive Outcomes and Psychiatric Symptoms of Retinopathy-Positive Cerebral Malaria: Cohort Description and Baseline Results.

Rachel Brim1, Sebastian Mboma2, Margaret Semrud-Clikeman3, Sam Kampondeni2, Jed Magen4, Terrie Taylor2,1, John Langfitt5.   

Abstract

Cerebral malaria (CM) is a common cause of death and disability among children in sub-Saharan Africa. Many prior studies of neuropsychiatric morbidity have been limited by a cross-sectional design or a short duration of follow-up. Most have included subjects who may have presented with coma due to a disease process other than CM. No studies have assessed the relationship between magnetic resonance imaging (MRI) findings and long-term outcomes. The Cognitive Outcomes and Psychiatric symptoms of retinopathy-positive CM (COPS) cohort is the first large (N = 221) prospectively recruited cohort of stringently defined cases of CM and hospital-based, age-matched, non-CM controls in whom cognitive and psychiatric outcomes are assessed with standardized measures semi-annually for up to 5 years. We report baseline characteristics of the cohort and outcomes at 1 month. At enrollment, CM cases were more likely to come from families with fewer socioeconomic resources and to have health characteristics that increase risk for malaria. In children younger than 5 years, cases were delayed in motor, language, and social development by approximately 6 months, compared with controls. More significant delays occurred in those with MRI abnormalities at the 1-month follow-up visit. There were no differences between cases and controls in inhibitory self-control, nor in cognitive function in children ≥ 5 years of age. The latter finding may be related to the smaller sample size, case-control imbalance in socioeconomic status, or the use of cognitive and behavioral assessments that are less culturally appropriate to this population. Continued follow-up will help determine predictors of long-term outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 28719298      PMCID: PMC5508917          DOI: 10.4269/ajtmh.17-0020

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Cognitive impairment after cerebral malaria in children: a prospective study.

Authors:  Michael J Boivin; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Chandy C John
Journal:  Pediatrics       Date:  2007-01-15       Impact factor: 7.124

2.  Risk factors for persisting neurological and cognitive impairments following cerebral malaria.

Authors:  R Idro; J A Carter; G Fegan; B G R Neville; C R J C Newton
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

3.  Cerebral malaria retinopathy predictors of persisting neurocognitive outcomes in Malawian children.

Authors:  Michael J Boivin; Maclean Vokhiwa; Alla Sikorskii; Jed G Magen; Nicholas A V Beare
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

4.  Statistical Approaches to Assess the Effects of Disease on Neurocognitive Function Over Time.

Authors:  Tracy L Bergemann; Paul Bangirana; Michael J Boivin; John E Connett; Bruno J Giordani; Chandy C John
Journal:  J Biom Biostat       Date:  2012-12-19

5.  Developmental outcomes in Malawian children with retinopathy-positive cerebral malaria.

Authors:  Michael J Boivin; Melissa J Gladstone; Maclean Vokhiwa; Gretchen L Birbeck; Jed G Magen; Connie Page; Margaret Semrud-Clikeman; Felix Kauye; Terrie E Taylor
Journal:  Trop Med Int Health       Date:  2010-12-08       Impact factor: 2.622

6.  Cognitive sequelae of severe malaria with impaired consciousness.

Authors:  P A Holding; J Stevenson; N Peshu; K Marsh
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Sep-Oct       Impact factor: 2.184

7.  Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study.

Authors:  Gretchen L Birbeck; Malcolm E Molyneux; Peter W Kaplan; Karl B Seydel; Yamikani F Chimalizeni; Kondwani Kawaza; Terrie E Taylor
Journal:  Lancet Neurol       Date:  2010-11-04       Impact factor: 44.182

8.  Cerebral malaria in children is associated with long-term cognitive impairment.

Authors:  Chandy C John; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Baolin Wu; Michael J Boivin
Journal:  Pediatrics       Date:  2008-06-09       Impact factor: 7.124

9.  Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children.

Authors:  Richard Idro; Moses Ndiritu; Bernhards Ogutu; Sadik Mithwani; Kathryn Maitland; James Berkley; Jane Crawley; Gregory Fegan; Evasius Bauni; Norbert Peshu; Kevin Marsh; Brian Neville; Charles Newton
Journal:  JAMA       Date:  2007-05-23       Impact factor: 56.272

10.  Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour.

Authors:  Paul Bangirana; Seggane Musisi; Michael J Boivin; Anna Ehnvall; Chandy C John; Tracy L Bergemann; Peter Allebeck
Journal:  Malar J       Date:  2011-11-03       Impact factor: 2.979

View more
  9 in total

Review 1.  Dementia in Africa: Current evidence, knowledge gaps, and future directions.

Authors:  Rufus O Akinyemi; Joseph Yaria; Akin Ojagbemi; Maëlenn Guerchet; Njideka Okubadejo; Alfred K Njamnshi; Fred S Sarfo; Albert Akpalu; Godwin Ogbole; Temitayo Ayantayo; Thierry Adokonou; Stella-Maria Paddick; David Ndetei; Judith Bosche; Biniyam Ayele; Andrea Damas; Motunrayo Coker; Lingani Mbakile-Mahlanza; Kirti Ranchod; Kirsten Bobrow; Udunna Anazodo; Albertino Damasceno; Sudha Seshadri; Margaret Pericak-Vance; Brian Lawlor; Bruce L Miller; Mayowa Owolabi; Olusegun Baiyewu; Richard Walker; Oye Gureje; Rajesh N Kalaria; Adesola Ogunniyi
Journal:  Alzheimers Dement       Date:  2021-09-27       Impact factor: 16.655

Review 2.  Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria.

Authors:  Katherine Plewes; Gareth D H Turner; Arjen M Dondorp
Journal:  Curr Opin Infect Dis       Date:  2018-02       Impact factor: 4.915

Review 3.  Pathophysiology and neurologic sequelae of cerebral malaria.

Authors:  Nicoline Schiess; Andres Villabona-Rueda; Karissa E Cottier; Katherine Huether; James Chipeta; Monique F Stins
Journal:  Malar J       Date:  2020-07-23       Impact factor: 2.979

4.  Aetiology and outcome of non-traumatic coma in African children: protocol for a systematic review and meta-analysis.

Authors:  Stephen T J Ray; Charlotte Fuller; Alexandra Boubour; Laura J Bonnett; David G Lalloo; Karl B Seydel; Michael J Griffiths
Journal:  Syst Rev       Date:  2021-10-29

Review 5.  Systemic Response to Infection Induces Long-Term Cognitive Decline: Neuroinflammation and Oxidative Stress as Therapeutical Targets.

Authors:  Patricia Alves Reis; Hugo Caire Castro-Faria-Neto
Journal:  Front Neurosci       Date:  2022-02-18       Impact factor: 4.677

6.  Delayed presentation to hospital care is associated with sequelae but not mortality in children with cerebral malaria in Malawi.

Authors:  Arabella Borgstein; Bo Zhang; Colin Lam; Montfort Bernard Gushu; Alice Wangui Liomba; Albert Malenga; Paul Pensulo; Andrew Tebulo; Dylan S Small; Terrie Taylor; Karl Seydel
Journal:  Malar J       Date:  2022-02-22       Impact factor: 2.979

Review 7.  Malaria Related Neurocognitive Deficits and Behavioral Alterations.

Authors:  Pamela Rosa-Gonçalves; Flávia Lima Ribeiro-Gomes; Cláudio Tadeu Daniel-Ribeiro
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293

8.  "I do lack peace, and I've run out of answers": primary caregivers' perspectives on social and behaviour problems in cerebral malaria survivors in Blantyre, Malawi.

Authors:  Savannah Karmen-Tuohy; Sebastian M Mboma; John T Langfitt; Rachel Brim; Melissa Gladstone; Terrie E Taylor
Journal:  Malar J       Date:  2022-04-13       Impact factor: 2.979

Review 9.  Severe malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2022-10-06       Impact factor: 3.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.